19-2253656-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_144616.4(JSRP1):c.400G>A(p.Val134Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000077 in 1,507,466 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_144616.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
JSRP1 | NM_144616.4 | c.400G>A | p.Val134Met | missense_variant | 5/7 | ENST00000300961.10 | NP_653217.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
JSRP1 | ENST00000300961.10 | c.400G>A | p.Val134Met | missense_variant | 5/7 | 2 | NM_144616.4 | ENSP00000300961 | P1 | |
JSRP1 | ENST00000593238.2 | downstream_gene_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000657 AC: 10AN: 152242Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000212 AC: 22AN: 103884Hom.: 0 AF XY: 0.000293 AC XY: 17AN XY: 58090
GnomAD4 exome AF: 0.0000782 AC: 106AN: 1355108Hom.: 1 Cov.: 34 AF XY: 0.000100 AC XY: 67AN XY: 668920
GnomAD4 genome AF: 0.0000656 AC: 10AN: 152358Hom.: 0 Cov.: 33 AF XY: 0.0000805 AC XY: 6AN XY: 74506
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 17, 2024 | The c.400G>A (p.V134M) alteration is located in exon 5 (coding exon 4) of the JSRP1 gene. This alteration results from a G to A substitution at nucleotide position 400, causing the valine (V) at amino acid position 134 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at